DB17703ExperimentalGene Therapies
Coagulin-B is an adeno-associated viral vector expressing human blood-coagulation Factor IX. It was previously investigated for the treatment of hemophilia; however, the manufacturing company discontinued the Phase I trial in...
- Also known as
- AAV-CMV-hF.IX · Coagulin B
Resolves to
Compound
What you can answer from here — as of April 02, 2025
Which companies are running trials of Coagulin-B, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account